The human ELF3 gene displays a notable upregulation in human malignancies, associated with poor survival outcomes in HER2+ breast cancer patients [56] and poor diagnosis in patients with papillary thyroid cancer [57]. The gene discussed is ERBB2; the disease is breast carcinoma.